NPI: 1720056203 · NORTH MIAMI BEACH, FL 33162 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,509 | $2.34M |
| 2019 | 26,681 | $3.32M |
| 2020 | 29,417 | $2.96M |
| 2021 | 20,859 | $834K |
| 2022 | 1,006 | $139K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 31,789 | 1,279 | $2.87M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,532 | 1,564 | $2.70M |
| J1270 | Injection, doxercalciferol, 1 mcg | 21,307 | 1,278 | $2.04M |
| A4657 | Syringe, with or without needle, each | 2,495 | 1,406 | $494K |
| J1756 | Injection, iron sucrose, 1 mg | 3,833 | 570 | $373K |
| 82728 | 1,949 | 1,232 | $201K | |
| 83540 | 2,013 | 1,253 | $191K | |
| 83550 | 2,015 | 1,254 | $191K | |
| 85041 | 1,757 | 1,080 | $172K | |
| 85048 | 1,752 | 1,074 | $172K | |
| 83970 | 1,154 | 724 | $117K | |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 212 | 136 | $33K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 496 | 270 | $22K |
| 82108 | 104 | 61 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 64 | 45 | $8K |